Prevalence of and factors associated with COVID-19 diagnosis in symptomatic patients followed in general practices in Germany between March 2020 and March 2021.

Louis Jacob, Ai Koyanagi, Lee Smith, Josep Maria Haro, Anna M Rohe, Karel Kostev
Author Information
  1. Louis Jacob: Research and Development Unit, Parc Sanitari Sant Joan de Déu, Dr. Antoni Pujadas, 42, Sant Boi de Llobregat, Barcelona 08830, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain; Faculty of Medicine, University of Versailles Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux 78180, France.
  2. Ai Koyanagi: Research and Development Unit, Parc Sanitari Sant Joan de Déu, Dr. Antoni Pujadas, 42, Sant Boi de Llobregat, Barcelona 08830, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Pg. Lluis Companys 23, Barcelona 08010, Spain.
  3. Lee Smith: Centre for Health, Performance and Wellbeing, Anglia Ruskin University, Cambridge, UK.
  4. Josep Maria Haro: Research and Development Unit, Parc Sanitari Sant Joan de Déu, Dr. Antoni Pujadas, 42, Sant Boi de Llobregat, Barcelona 08830, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.
  5. Anna M Rohe: Department of Otorhinolaryngology, Head and Neck Surgery, Solingen Municipal Hospital, Solingen, Germany.
  6. Karel Kostev: Epidemiology, IQVIA, Frankfurt, Germany. Electronic address: karel.kostev@iqvia.com.

Abstract

AIMS: This study aimed to investigate the prevalence of and the factors associated with the diagnosis of coronavirus disease 2019 (COVID-19) in symptomatic patients followed in general practices in Germany between March 2020 and March 2021.
METHODS: Symptomatic patients tested for COVID-19 and followed in one of 962 general practices in Germany from March 2020 to March 2021 were included in this study. Covariates included sex, age, and comorbidities present in at least 3% of the population. The association between these factors and the diagnosis of COVID-19 was analyzed using an adjusted logistic regression model.
RESULTS: A total of 301,290 patients tested for COVID-19 were included in this study (54.7% women; mean [SD] age 44.6 [18.5] years). The prevalence of COVID-19 was 13.8% in this sample. Male sex and older age were positively and significantly associated with COVID-19. In terms of comorbidities, the strongest positive associations with COVID-19 were observed for cardiac arrhythmias, depression, and obesity. There was also a negative relationship between the odds of being diagnosed with COVID-19 and several conditions such as chronic sinusitis, asthma, and anxiety disorders.
CONCLUSIONS: Approximately 14% of symptomatic patients tested for COVID-19 were diagnosed with COVID-19 in German general practices from March 2020 to March 2021.

Keywords

References

  1. Obes Med. 2020 Sep;19:100283 [PMID: 32835126]
  2. Proc Natl Acad Sci U S A. 2020 Nov 3;117(44):27285-27291 [PMID: 33060298]
  3. Am J Infect Control. 2021 May;49(5):542-546 [PMID: 33896582]
  4. Aging (Albany NY). 2020 May 29;12(10):9959-9981 [PMID: 32470948]
  5. Int J Clin Pharmacol Ther. 2018 Oct;56(10):459-466 [PMID: 30168417]
  6. Lancet Psychiatry. 2021 Feb;8(2):130-140 [PMID: 33181098]
  7. Chron Respir Dis. 2021 Jan-Dec;18:14799731211029658 [PMID: 34219501]
  8. Lancet Infect Dis. 2020 Sep;20(9):1034-1042 [PMID: 32422204]
  9. World Psychiatry. 2021 Feb;20(1):124-130 [PMID: 33026219]
  10. BMJ Open. 2020 Dec 17;10(12):e044079 [PMID: 33334842]
  11. J Allergy Clin Immunol Pract. 2021 Feb;9(2):693-701 [PMID: 33309934]
  12. J Am Coll Emerg Physicians Open. 2020 May 22;: [PMID: 32838371]
  13. J Interv Card Electrophysiol. 2020 Nov;59(2):329-336 [PMID: 32494896]
  14. Lancet Public Health. 2021 Jan;6(1):e30-e38 [PMID: 33308423]
  15. Clin Infect Dis. 2020 Oct 27;: [PMID: 33105485]
  16. J Clin Virol. 2020 Jun;127:104371 [PMID: 32315817]
  17. J Asthma. 2020 Sep 17;:1-7 [PMID: 32878518]
  18. JCI Insight. 2020 May 21;5(10): [PMID: 32352933]
  19. Front Med (Lausanne). 2021 Jun 02;8:613537 [PMID: 34150788]
  20. Cell. 2020 May 28;181(5):1016-1035.e19 [PMID: 32413319]
  21. J Intern Med. 2021 Jun;289(6):921-925 [PMID: 33372300]
  22. Int J Clin Pract. 2021 Apr;75(4):e13788 [PMID: 33128270]
  23. Clin Infect Dis. 2020 Dec 17;71(10):2702-2707 [PMID: 32548613]
  24. Clin Infect Dis. 2020 Jul 28;71(15):799-806 [PMID: 32271376]
  25. Nat Rev Immunol. 2020 Jul;20(7):442-447 [PMID: 32528136]
  26. Tohoku J Exp Med. 2020;250(4):271-278 [PMID: 32321874]
  27. J Clin Nurs. 2021 Jun;30(11-12):1719-1729 [PMID: 33616300]
  28. Int J Environ Res Public Health. 2021 Mar 11;18(6): [PMID: 33799609]
  29. Infect Control Hosp Epidemiol. 2020 Sep;41(9):1093-1094 [PMID: 32507115]
  30. CMAJ. 2021 May 17;193(20):E723-E734 [PMID: 33906966]
  31. Ann Allergy Asthma Immunol. 2021 May;126(5):535-541.e2 [PMID: 33639262]
  32. Vaccines (Basel). 2021 Mar 11;9(3): [PMID: 33799505]
  33. Epidemiol Infect. 2020 Dec 22;149:e11 [PMID: 33349290]
  34. PLoS One. 2020 Dec 28;15(12):e0244533 [PMID: 33370347]
  35. Emerg Infect Dis. 2021 Jan;27(1): [PMID: 33261716]
  36. J Infect. 2020 Dec;81(6):847-856 [PMID: 33049331]
  37. Euro Surveill. 2020 Nov;25(47): [PMID: 33243353]
  38. Ann Intern Med. 2021 Jan;174(1):69-79 [PMID: 32941052]
  39. Proc Nutr Soc. 2012 May;71(2):298-306 [PMID: 22414338]

MeSH Term

Adult
Aged
COVID-19
COVID-19 Testing
Female
Germany
Humans
Male
Prevalence
SARS-CoV-2

Word Cloud

Created with Highcharts 10.0.0COVID-19MarchpatientspracticesfactorsdiagnosisgeneralGermany20202021studyassociatedsymptomaticfollowedtestedincludedageprevalenceSymptomaticsexcomorbiditiesdiagnosedPrevalenceAIMS:aimedinvestigatecoronavirusdisease2019METHODS:one962Covariatespresentleast3%populationassociationanalyzedusingadjustedlogisticregressionmodelRESULTS:total301290547%womenmean[SD]446[185]years138%sampleMaleolderpositivelysignificantlytermsstrongestpositiveassociationsobservedcardiacarrhythmiasdepressionobesityalsonegativerelationshipoddsseveralconditionschronicsinusitisasthmaanxietydisordersCONCLUSIONS:Approximately14%GermanAssociatedGeneral

Similar Articles

Cited By